The LPWWC Bladder Care Program

Two programs, predictable payments, and a structured approach to treatment.

LARAMIE PHYSICIANS WOMEN & WELLNESS CLINIC

Pelvic Wellness Library · Volume 04 · Editorial version: October 20, 2026

Pelvic Wellness Library

Welcome

When you explore care, you should be able to understand both the clinical proposal and the financial proposal. A longer payment schedule does not necessarily mean a longer initial treatment phase. A combined program does not automatically mean more separate appointments. Clear distinctions help you ask questions before making any commitment.

This guide explains LPWWC’s two proposed annual programs using the same configuration as the program page. Prices, inclusions and written terms require final approval. Online enrollment and payment are not available. This book is not an agreement or a personal treatment recommendation, and it does not establish that the programs are suitable for you.

Chapter 1

Chapter 1. Two proposed options, not three tiers

Bladder Control is a proposed program centered on vTone pelvic-floor electrical stimulation. Its initial phase proposes 6 vTone treatments. Whether electrical stimulation is appropriate depends on clinical evaluation; urinary leakage alone does not establish suitability. Other explanations and established care approaches must remain part of the conversation. [1, 2]

Bladder + Pelvic Restore proposes 6 vTone treatments plus 3 FormaV radiofrequency modalities when a physician considers tissue-directed treatment appropriate. Electrical stimulation and radiofrequency are different mechanisms. Evidence or clearance for vTone cannot be used to assert the same indication for FormaV. The combined proposal is not an FDA-approved membership. [2, 3]

MorpheusV / Morpheus8V is an optional separate physician-directed consideration. It is not a third standard membership, a required upgrade or an automatic inclusion. Any recommendation, treatment count, interval and separate price must come from the clinic’s approved care process. This guide does not estimate them.

The distinction between programs is clinical as well as financial. More modalities do not make a program universally preferable. Ask what findings support an option and what alternatives, including conservative care, should be considered. Exploration on the website is only interest; it does not assign treatment.

KEY TAKEAWAY: There are exactly two proposed standard programs. Optional additional care remains separate and physician-directed.

Chapter 2

Chapter 2. Put the numbers in context

The financial comparison separates one-time enrollment from twelve monthly payments. Both elements contribute to the proposed first-year total. A monthly amount is a payment illustration for a defined annual agreement, not permission to treat the arrangement as freely cancelable month-to-month care.

Proposed program comparison

The proposed difference is $80 per monthly payment and $300 at enrollment. The difference in proposed first-year totals is $1,260. These calculations do not include an optional separately quoted procedure or a future maintenance pathway. No maintenance price or included annual treatment count is confirmed here.

Monthly payments are proposed to begin 30 days after enrollment. Initial treatments may finish before the payment schedule does. Payment timing does not create a monthly visit entitlement and does not determine whether a clinician should add a treatment. A calendar for payments and a calendar for clinical care serve different purposes.

The $99 Bladder Control monthly figure supersedes an earlier proposal’s $125 for this draft. Final pricing still requires clinic confirmation. Do not rely on this educational edition as a signed agreement or an assurance that purchase is available. Ask for approved written terms before any enrollment becomes possible.

NUMBERS IN CONTEXT: Enrollment plus twelve payments produces the first-year total. A monthly figure by itself does not represent the whole proposed cost.

Chapter 3

Chapter 3. Understand the six-week proposal

The initial vTone schedule proposes one treatment each week for six weeks. In the combined program, FormaV is proposed at selected visits in Weeks 1, 3, 5. These are draft clinic adaptations, not universal treatment instructions. Actual scheduling, suitability and procedure details require clinical approval.

Proposed care timeline

The combined program has nine proposed modality treatments, not necessarily nine separate appointments. Some modalities may share a visit when approved. This distinction helps avoid overstating the practical burden or presenting every modality as a separate booking.

Published research is not identical to this schedule. The cited electrical-stimulation trial used an eight-week regimen in a specific population. The combined RF, rehabilitation and education study used three combined treatments two weeks apart. Neither establishes the exact proposed six-plus-three LPWWC program or guarantees an individual result. [4, 5]

If an appointment is missed or a clinical concern arises, the next step belongs in a conversation with the team. This draft does not invent a rescheduling rule, cancellation term, refund policy or automatic replacement treatment. Those terms must be provided in an approved agreement and individualized care plan.

WHAT WE DON’T KNOW YET: The final protocol, scheduling arrangements and written membership terms remain subject to clinic approval.

Chapter 4

Chapter 4. Clinical evaluation comes before activation

A program description cannot assess medical history, symptoms, examination findings or device contraindications. The clinical team must determine whether these treatments, conservative care, a different intervention or further investigation is appropriate. Do not use the program price or a preferred technology as a substitute for that evaluation. [1]

The current Smart Routing area is a placeholder. It does not collect clinical answers, establish suitability, book care or accept payment. Selecting an interest on the page identifies what you are exploring; it does not enroll you or create a patient-care record. Contact the clinic through its existing pathway for an appropriate discussion.

Before any future enrollment, ask what the approved program includes, what is separately quoted and how risks and alternatives will be explained. Specific preparation, aftercare and procedure instructions must come from the clinical team and exact device documentation, not from a general book or a financial comparison.

There is no working merchant checkout in this draft. No educational button or guide request is evidence of payment. Do not assume an agreement is signed, a membership is activated or appointments are created merely because you have read the page or expressed interest.

QUICK ANSWER: “Does exploring a program start treatment or billing?” No. Exploration is not clinical clearance, enrollment, payment or scheduling.

Chapter 5

Chapter 5. Reassessment is a decision point

After the initial phase, the team should review symptoms and response. Meaningful improvement may lead to discussion of appropriate follow-up. Partial improvement may prompt a conversation about further evaluation or limited additional care. Minimal improvement calls for reassessment rather than assuming more device sessions are automatically the answer.

These descriptions are educational possibilities, not an automatic branching rule. A patient cannot be assigned to a maintenance or additional-treatment pathway from a book. Decisions should consider symptoms, findings, adverse effects, goals and other appropriate options.

Maintenance remains a separate future pathway under review. This book confirms no maintenance fee, recurring treatment count or automatic renewal. Do not add a hypothetical maintenance cost to the first-year total or assume it is included. If an offer is developed, ask for approved clinical and financial terms before agreeing.

Questions to bring

• Why is a particular option being considered for me?
• What are the approved inclusions and separate costs?
• How do payment timing and visit timing differ?
• What current evidence and device labeling support the intended use?
• What happens if improvement is limited or treatment must change?
• Which cancellation, refund and scheduling terms will appear in the final agreement?

Compare the proposed programs at https://laramiephysicians.com/bladder-control-pelvic-restoration/ or contact LPWWC at (307) 745-8991 and https://laramiephysicians.com/contact/. These are educational and existing contact destinations, not a new booking workflow.

BEFORE YOU GO: Understand the proposal, then ask for a clinical recommendation and approved written terms before committing.

Pelvic Wellness Library

References and educational context

[1] ACOG. Urinary Incontinence. Patient FAQ; accessed October 20, 2026. https://www.acog.org/womens-health/faqs/urinary-incontinence

[2] FDA. InMode System with vTone Applicator, K200293. May 5, 2020. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K200293

[3] Medsafe. The USFDA Warns Against Use of Energy-Based Devices to Perform Vaginal Rejuvenation or Vaginal Cosmetic Procedures. September 5, 2018; historical safety context, not current device clearance. https://www.medsafe.govt.nz/safety/EWS/2018/EnergyBasedDevicesVaginalRejuvenation.asp

[4] Intravaginal electrical stimulation increases voluntarily pelvic floor muscle contractions in women who are unable to voluntarily contract their pelvic floor muscles: a randomised trial. 2022. https://pubmed.ncbi.nlm.nih.gov/34952812/

[5] Bipolar Radiofrequency Treatment of the Vaginal Canal in Conjunction with Patient Education and Pelvic Floor Rehabilitation for the Treatment of Women with Mixed Urinary Incontinence. 2024. https://doi.org/10.1089/gyn.2023.0142

Program figures and schedule derive from LPWWC’s proposed catalog, version October 20, 2026. The original MERIDIAN-105 clinical deck was not available for this edition. Clinical, pricing and agreement approval remain pending. General education only; no physician approval, authorship, individual clearance or results guarantee is asserted. LPWWC, 1277 N 15th St, Laramie, WY 82072.